2,335
Views
22
CrossRef citations to date
0
Altmetric
Special issue on laminopathies

Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes

, , , , , , , , , , , , ORCID Icon, , , , , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 337-349 | Received 19 Mar 2018, Accepted 17 Apr 2018, Published online: 18 May 2018

References

  • Maggi L, D'Amico A, Pini A, et al. LMNA-associated myopathies: the Italian experience in a large cohort of patients. Neurology. 2014;83:1634–44.
  • Carboni N, Mura M, Marrosu G, et al. Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve. 2010;41:458–63.
  • Ben Yaou R, Toutain A, Arimura T, Demay L, Massart C, Peccate C, et al. Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism? Neurology. 2007;68:1883–94.
  • Camozzi D, Capanni C, Cenni V, et al. Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies. Nucleus. 2014;5:427–40.
  • Cenni V, Sabatelli P, Mattioli E, et al. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy. J Med Genet. 2005;42:214–20.
  • Mattioli E, Columbaro M, Capanni C, et al. Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle. Cell Death Differ. 2011;18:1305–15.
  • Mattout A, Pike BL, Towbin BD, et al. An EDMD mutation in C. elegans lamin blocks muscle-specific gene relocation and compromises muscle integrity. Curr Biol: CB. 2011;21:1603–14.
  • Rufo A, Del Fattore A, Capulli M, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Re.: Official J Am Society Bone Miner Res. 2011;26:1891–903.
  • Biressi S, Miyabara EH, Gopinath SD, et al. A Wnt-TGFbeta2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Sci Transl Med. 2014;6:267.ra176.
  • Lamar KM, Bogdanovich S, Gardner BB, et al. Overexpression of Latent TGFbeta Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFbeta. PLoS Genetics. 2016;12:e1006019.
  • Evangelisti C, Bernasconi P, Cavalcante P, et al. Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. Oncotarget. 2015;6:7424–37.
  • Evangelisti C, Cenni V, Lattanzi G. Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders. Br J Clin Pharmacol. 2016;82:1229–44.
  • Chatzifrangkeskou M, Le Dour C, Wu W, Morrow JP, et al. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene. Hum Mol Genet. 2016;25:2220–33.
  • Choi JC, Muchir A, Wu W, et al. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med. 2012;4:144.ra02.
  • Ramos FJ, Kaeberlein M, Kennedy BK. Elevated MTORC1 signaling and impaired autophagy. Autophagy. 2013;9:108–9.
  • Ramos FJ, Chen SC, Garelick MG, et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med. 2012;4:144.ra03.
  • Cesarini E, Mozzetta C, Marullo F, et al. Lamin A/C sustains PcG protein architecture, maintaining transcriptional repression at target genes. J Cell Biol. 2015;211:533–51.
  • Sabatelli P, Gualandi F, Gara SK, et al. Expression of collagen VI alpha5 and alpha6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis. Matrix Biol: J Int Society Matrix Biol. 2012;31:187–96.
  • Avnet S, Pallotta R, Perut F, et al. Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. Biochim Biophys Acta. 2011;1812:711–8.
  • Meinke P, Schneiderat P, Srsen V, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord: NMD. 2015;25:127–36.
  • Liu H, Zhang C, Zhu S, et al. Mohawk promotes the tenogenesis of mesenchymal stem cells through activation of the TGFbeta signaling pathway. Stem Cells. 2015;33:443–55.
  • Brown JP, Finley VG, Kuo CK. Embryonic mechanical and soluble cues regulate tendon progenitor cell gene expression as a function of developmental stage and anatomical origin. J Biomech. 2014;47:214–22.
  • Bertacchini J, Beretti F, Cenni V, et al. The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression. FASEB J: Official Publicat Federation Am Societies Experiment Biol. 2013;27:2145–55.
  • Cenni V, Capanni C, Mattioli E, et al. Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics. Aging. 2014;6:755–70.
  • Cenni V, D'Apice MR, Garagnani P, et al. Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing. Ageing Res Rev. 2017;42:1–13.
  • Suprynowicz FA, Kamonjoh CM, Krawczyk E, et al. Conditional cell reprogramming involves non-canonical beta-catenin activation and mTOR-mediated inactivation of Akt. PloS One. 2017;12:e0180897.
  • Mitra A, Luna JI, Marusina AI, et al. Dual mTOR Inhibition Is Required to Prevent TGF-beta-Mediated Fibrosis: Implications for Scleroderma. J Invest Dermatol. 2015;135:2873–6.
  • Le Dour C, Macquart C, Sera F, Homma S, et al. Decreased WNT/beta-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333–43.
  • Ueno M, Carvalheira JB, Tambascia RC, et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia. 2005;48:506–18.
  • Nardella C, Lunardi A, Fedele G, et al. Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. Cancer Res. 2011;71:3669–75.
  • Madej-Pilarczyk A, Niezgoda A, Janus M, et al. Limb-girdle muscular dystrophy with severe heart failure overlapping with lipodystrophy in a patient with LMNA mutation p.Ser334del. J Appl Genet. 2017;58:87–91.
  • Russo V, Papa AA, Williams EA, et al. ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies. Trends Cardiovasc Med. 2017.
  • Captur G, Arbustini E, Bonne G, et al. Lamin and the heart. Heart. 2018;104:468–79.
  • Asahara H, Inui M, Lotz MK. Tendons and Ligaments: Connecting Developmental Biology to Musculoskeletal Disease Pathogenesis. J Bone Miner Res: Official J Am Society Bone Miner Res. 2017;32:1773–82.
  • Angori S, Capanni C, Faulkner G, et al. Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress. Cell Physiol Biochem. 2017;42:169–84.